Dashboard
The company has declared Positive results for the last 8 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 186.7 MM
- NET PROFIT(HY) Higher at USD -167.87 MM
- DEBTORS TURNOVER RATIO(HY) Highest at 6.09 times
Risky - Negative EBITDA
High Institutional Holdings at 100%
Consistent Returns over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
USD 22,974 Million (Mid Cap)
NA (Loss Making)
NA
0.00%
-0.74
-20.32%
18.44
Total Returns (Price + Dividend) 
Natera, Inc. for the last several years.
Risk Adjusted Returns v/s 
News

Natera, Inc. Hits New 52-Week High of $203.22, Up 75.94%
Natera, Inc. has achieved a new 52-week high, reflecting its strong performance with a notable increase over the past year. The company, with a market capitalization of approximately USD 22,974 million, operates in a competitive sector and continues to attract attention despite its loss-making status and unique financial metrics.
Read More
Natera, Inc. Hits New 52-Week High of $200.76, Showcasing Strong Growth
Natera, Inc. has achieved a new 52-week high, reflecting a significant performance increase over the past year, outpacing broader market growth. Despite operating at a loss, the company maintains a substantial market capitalization and unique financial metrics, highlighting its notable presence in the pharmaceuticals and biotechnology sector.
Read More
Natera, Inc. Hits New 52-Week High of $199.21, Up 78.16%
Natera, Inc. has achieved a new 52-week high, reflecting its strong performance with a significant increase over the past year. The company, with a market capitalization of approximately USD 22,974 million, operates in a competitive biotechnology sector, attracting attention despite its loss-making status and notable financial metrics.
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 113 Schemes (44.1%)
Held by 291 Foreign Institutions (14.53%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 32.22% vs 58.15% in Jun 2024
YoY Growth in quarter ended Jun 2025 is -169.07% vs 66.16% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 56.74% vs 31.99% in Dec 2023
YoY Growth in year ended Dec 2024 is 56.21% vs 20.63% in Dec 2023






